The following Press Release was issued today by Cell Press and may be of
interest to readers of these lists.  Please excuse the cross-posting.
D. Menefee
Library Relations
Elsevier
 
 
Cell debuts design changes and expanded scientific coverage

Cambridge, December 2, 2005- Cell, a scientific journal published by
Elsevier imprint Cell Press, has launched a new section, called Leading
Edge, which adds pages of analysis, commentary, and essays to the popular
review formats-which include full reviews, minireviews, and previews-in each
issue. 

The new design maintains the journal's classic look while incorporating
features including an updated typeface, illustrations and graphics with a
consistent style, and more color throughout.

"The Leading Edge section will feature in-depth analytical articles by
science writers, and essays and commentaries by eminent scientists," Cell
Editor Emilie Marcus explains. "In a time of increasing scientific
specialization, we feel a responsibility to support the progress of science
by promoting interdisciplinary communication. All of our content and design
changes will support these goals while maintaining Cell's reputation for
high standards of research and communicating conceptual scientific
advances."

The changes debut in the December 2, 2005 issue, which is freely available
online, at  <http://www.cell.com/content/issue?volume=123&issue=5>
www.cell.com/content/issue?volume=123&issue=5.

About Cell Press: Cell Press (www.CellPress.com <http://www.cellpress.com/>
) an imprint of Elsevier, is committed to improving scientific communication
through the publication of exciting biology research and reviews. Cell Press
journals include the flagship journal Cell (www.cell.com
<http://www.cell.com/> ), Neuron (www.neuron.org <http://www.neuron.org/> ),
Immunity (www.immunity.com <http://www.immunity.com/> ), Molecular Cell
(www.molecule.org <http://www.molecule.org/> ), Developmental Cell
(www.developmentalcell.com <http://www.developmentalcell.com/> ), Cancer
Cell (www.cancercell.org <http://www.cancercell.org/> ), Current Biology
(www.current-biology.com <http://www.current-biology.com/> ), Structure
(www.structure.org <http://www.structure.org/> ), Chemistry & Biology
(www.chembiol.com <http://www.chembiol.com/> ), and the new journal Cell
Metabolism (www.cellmetabolism.org <http://www.cellmetabolism.org/> ), which
launched in January 2005. Cell Press's mission is to continue to publish and
develop journals that deliver the highest possible intellectual rigor,
promote community trust, and are widely disseminated. 

              

About Elsevier: Elsevier is a world-leading publisher of scientific,
technical and medical information products and services. Working in
partnership with the global science and health communities, Elsevier's 7,000
employees in 71 offices worldwide publish more than 2,000 journals and 2,200
new books per year, in addition to offering a suite of innovative electronic
products, such as ScienceDirect ,MD Consult, Scopus, bibliographic
databases, and online reference works.

Elsevier (elsevier.com) is a global business headquartered in Amsterdam, The
Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier
Group plc (reedelsevier.com), a world-leading publisher and information
provider. Operating in the science and medical, legal, education and
business-to-business sectors, Reed Elsevier provides high-quality and
flexible information solutions to users, with increasing emphasis on the
Internet as a means of delivery. Reed Elsevier's ticker symbols are REN
(Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York
Stock Exchange).  

Contact:
Heidi Hardman

Press Officer
Cell Press (an imprint of Elsevier)
600 Technology Square

5th Floor

Cambridge, MA 02139

 

+1 (617) 397-2879 phone
+1 (617) 397-2850 fax
+1 (857) 928-5630 mobile

[log in to unmask]
 <http://www.cellpress.com/> www.CellPress.com